Definitive Contract 75A50323C00031

Award Date 9/30/23
Potential Completion Date 3/28/25
Potential Value $8.4M
Awardee
Mriglobal
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Time and Materials
Place of Performance
Kansas City, MO 64110, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $4,517,664.65 firm fixed price delivery order contract awarded by the Department of State Bureau of Medical Services to Mriglobal, doing business as Midwest Research Institute, for the design and fabrication of portable biocontainment modules. No set-aside was used. Mriglobal is an independent, not-for-profit research organization that conducts over $110 million in research annually for federal and commercial customers, including work for the National Institutes of Health, Department...
This is a $500,000.00 definitive contract awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Mriglobal, doing business as Midwest Research Institute, a not-for-profit research organization. The contract is for IGF::OT::IGF FOR OTHER FUNCTIONS with a completion date of September 24, 2019. It is a firm fixed-price contract and was not set aside for any specific business type. Mriglobal conducts over $110 million in research annually for...
This is a $19,091,009.00 cost-plus-fixed-fee definitive contract awarded by a U.S. government agency to the not-for-profit research organization Mriglobal, doing business as Midwest Research Institute. The contract, which has no set-aside designation, is for research and development work and is set to be completed by November 15, 2005. Mriglobal specializes in areas such as medical countermeasure development, biosafety testing, threat detection technologies, and specialized training programs,...
This federal contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Mriglobal, doing business as Midwest Research Institute, a not-for-profit research organization. The contract has a firm fixed price of $118,030.00 and is a Blanket Purchase Agreement (BPA) call. The contract does not have a set-aside designation. Mriglobal conducts over $110 million in research annually for federal and commercial customers, and often serves as a prime...
This is a Delivery Order awarded under the Joint Enterprise Research Development Acquisition and Production-Procurement (JE-RDAP) Indefinite Delivery Contract. The $2,026,227.00 firm fixed-price contract was awarded by the Joint PEO Chemical and Biological Defense, a Defense agency, to procure three mobile medical laboratories for COVID-19 testing. The prime contractor is Mriglobal, doing business as Midwest Research Institute, a 501(c)(3) not-for-profit research organization based in Kansas...
This award is a BPA (Blanket Purchase Agreement) call made by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Mriglobal, doing business as Midwest Research Institute, a not-for-profit research organization. The contract has a potential value of $112,665.00 and a completion date of July 30, 2020. It was awarded on a Firm Fixed Price basis with no set-aside designation. Mriglobal is an experienced federal contractor, having received numerous...
This is a $112,665 firm-fixed-price contract awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Mriglobal, a not-for-profit research organization doing business as Midwest Research Institute. The award is not set aside for small businesses. The contract is for unspecified "other functions", indicating it may cover a range of services. Mriglobal has a history of supporting federal agencies like HHS, the Department of...
This is a $18,775,613.66 definitive contract awarded by the Department of Defense to Mriglobal, doing business as Midwest Research Institute, a not-for-profit research organization. The contract is for lab analysis and collection support services, with a completion date of August 28, 2022. It is a firm fixed price contract, with no set-aside designation. Mriglobal, as the prime contractor, has subcontracted a portion of the work to Steris Corporation, a foreign-owned for-profit manufacturer, for...
This is a $13,047,673.64 definitive cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Mriglobal (doing business as Midwest Research Institute), a 501(c)(3) not-for-profit research organization. The contract is for the Mycobacterium Tuberculosis (MTB) Quality Assessment Program (TBQA), with a period of performance through December 31, 2023. This contract was not set aside for any specific business type. Mriglobal...
This is a firm fixed-price delivery order contract awarded by the Washington Headquarters Service, a defense agency, to Mriglobal, a 501(c)(3) not-for-profit research organization doing business as Midwest Research Institute. The contract, valued at $96,840.00, is for special studies work. Mriglobal is a prime contractor that frequently partners with universities, research institutes, and small businesses to provide scientific research, testing, training, and product development services to...

This is a $8,362,057.66 federal contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to Mriglobal, a not-for-profit research organization based in Kansas City, Missouri. The contract requires the prime contractor to complete the design, fabrication, testing, and delivery of biocontainment units. The contract is a definitive contract with a time and materials pricing type, and does not have a set-aside designation. Mriglobal has a history of performing research and development work for federal agencies in areas such as medical countermeasure development, biosafety testing, and threat detection technologies. This award appears to be part of the agency's efforts to enhance biocontainment capabilities. The contract has a performance period through March 2025 and includes several subcontractors providing specialized components and equipment.

Generated 4/21/25, 3:54 AM